Publicaciones en las que colabora con ANDER MATHEU FERNÁNDEZ (25)

2024

  1. Identification of a novel gene signature related to prognosis and metastasis in gastric cancer

    Cellular Oncology

2023

  1. Metabolic rewiring induced by ranolazine improves melanoma responses to targeted therapy and immunotherapy

    Nature Metabolism, Vol. 5, Núm. 9, pp. 1544-1562

2022

  1. Chaperone-Mediated Autophagy Controls Proteomic and Transcriptomic Pathways to Maintain Glioma Stem Cell Activity

    Cancer Research, Vol. 82, Núm. 7, pp. 1283-1297

  2. High SOX9 Maintains Glioma Stem Cell Activity through a Regulatory Loop Involving STAT3 and PML

    International Journal of Molecular Sciences, Vol. 23, Núm. 9

  3. Impact of Cancer Stem Cells on Therapy Resistance in Gastric Cancer

    Cancers, Vol. 14, Núm. 6

  4. SOX9 Triggers Different Epithelial to Mesenchymal Transition States to Promote Pancreatic Cancer Progression

    Cancers, Vol. 14, Núm. 4

2021

  1. Identification of a dexamethasone mediated radioprotection mechanism reveals new therapeutic vulnerabilities in glioblastoma

    Cancers, Vol. 13, Núm. 2, pp. 1-23

2020

  1. Characterization of a new small-molecule inhibitor of HDAC6 in glioblastoma

    Cell Death and Disease, Vol. 11, Núm. 6

  2. Relevance of oxidative stress and inflammation in frailty based on human studies and mouse models

    Aging, Vol. 12, Núm. 10, pp. 9982-9999

  3. SOX9 promotes tumor progression through the axis BMI1-p21CIP

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Liquid biopsy in glioblastoma: Opportunities, applications and challenges

    Cancers, Vol. 11, Núm. 7

  2. SOX2 expression diminishes with ageing in several tissues in mice and humans

    Mechanisms of Ageing and Development, Vol. 177, pp. 30-36

  3. Therapeutic relevance of SOX9 stem cell factor in gastric cancer

    Expert Opinion on Therapeutic Targets, Vol. 23, Núm. 2, pp. 143-152

2018

  1. Integrin α7: A novel promising target in glioblastoma stem cells

    Stem Cell Investigation, Vol. 5, Núm. 1

  2. Towards precision medicine: linking genetic and cellular heterogeneity in gastric cancer

    Therapeutic Advances in Medical Oncology, Vol. 10

2017

  1. Increased Arf/p53 activity in stem cells, aging and cancer

    Aging Cell, Vol. 16, Núm. 2, pp. 219-225

  2. Oncogenic activity of SOX1 in glioblastoma

    Scientific Reports, Vol. 7

2016

  1. Inflammaging and frailty status do not result in an increased extracellular vesicle concentration in circulation

    International Journal of Molecular Sciences, Vol. 17, Núm. 7

  2. MTOR inhibition decreases SOX2-SOX9 mediated glioma stem cell activity and temozolomide resistance

    Expert Opinion on Therapeutic Targets, Vol. 20, Núm. 4, pp. 393-405

  3. Paradoxical role of SOX2 in gastric cancer

    American Journal of Cancer Research, Vol. 6, Núm. 4, pp. 701-713